|
| |
Accelrys and Agilent Technologies Enter Into
Comprehensive Resale Agreement
SAN DIEGO, Calif., and SANTA CLARA, Calif., Sept.
25, 2007 -- Accelrys Inc. (NASDAQ: ACCL) and Agilent Technologies Inc.
(NYSE: A) today announced they have entered into a comprehensive resale
agreement to enable the licensing and integration of their informatics products.
The partnership covers the breadth of informatics portfolios of both companies
and will enable customers in the pharmaceutical industry to enjoy unprecedented
integration of laboratory data, experimental results and insights across the
enterprise.
“This partnership will enable unparalleled integration of informatics products,”
said Bruce von Herrmann, Agilent vice president and general manager, Informatics
Division. “It will significantly benefit pharmaceutical companies that want to
spend less time integrating existing informatics solutions and more time
developing new, more effective medicines.”
Agilent and Accelrys will offer compatible and enhanced solutions incorporating
their respective portfolios of informatics products. Accelrys will resell
OpenLAB Enterprise Content Manager, Kalabie Electronic Lab Notebook, and
GeneSpring gene expression solutions. Agilent will resell Accord cheminformatics
solutions and Pipeline Pilot Scientific Operating Platform solutions.
“Partnering with Agilent allows us to provide a broader range of scientific
business-intelligence solutions to our pharmaceutical customers,” said Mark J.
Emkjer, president and chief executive officer, Accelrys. “We’re enabling them to
gain deeper insights and make more informed decisions from their scientific data
across the research and development continuum. Agilent’s strength in Laboratory
Informatics, QA/QC and manufacturing are a natural complement to Accelrys’
expertise in research, early development and scientific data management,”
The combined solutions can be seen at the following events:
o the Agilent Worldwide Laboratory Informatics Conference in Berlin on Sept.
25-26;
o the ELNs - IQPC conference in Brussels on Sept. 26; and
o the Accord Informatics and Scitegic Pipeline Pilot user group meeting in
Pistoia, Italy, Oct. 9-12.
About Agilent Technologies
Agilent Technologies Inc. (NYSE: A) is the world’s premier measurement
company and a technology leader in communications, electronics, life sciences
and chemical analysis. The company’s 19,000 employees serve customers in more
than 110 countries. Agilent had net revenue of $5.0 billion in fiscal 2006.
Information about Agilent is available on the Web at
www.agilent.com
.
About Accelrys
Accelrys develops and commercializes scientific business intelligence
software for the integration, mining, analysis, modeling and simulation,
management and interactive reporting of scientific data. Our solutions are used
by biologists, chemists, materials scientists, and information technology
professionals for product design as well as drug discovery and development. Our
technology and services are designed to meet the needs of today’s leading
research and development organizations including leading commercial, government
and academic organizations. For more information about Accelrys, visit its
website at
www.accelrys.com .
Forward-Looking Statements
This press release contains forward-looking statements. Such statements,
including statements relating to the results of the partnership between Agilent
and Accelrys, including statements relating to reducing cost of complexity for
customers, product integration and benefits to the companies and their
customers, are subject to risks and uncertainties including, but not limited to,
the risks that the partnership will not result in such integration or other
benefits, and that the companies’ products will not be timely or successfully
completed, developed or achieve market acceptance, demand relating to these
products, and other risks and uncertainties described in documents Accelrys has
filed with the Securities and Exchange Commission, including its most recent
report on Form 10-K and any subsequent interim filings. All forward-looking
statements in this document are qualified entirely by the cautionary statements
included in this document and such filings. These risks and uncertainties could
cause actual results to differ materially from results expressed or implied by
forward-looking statements contained in this document. These forward-looking
statements speak only as of the date of this document. Accelrys and Agilent
disclaim any intent or obligation to publicly update or revise any
forward-looking statements contained herein to reflect any change in their
expectations with regard thereto or any change in events, conditions or
circumstances on which any such statement is based.
# # #
NOTE TO EDITORS: Further technology, corporate citizenship and executive news is
available on the Agilent news site at
www.agilent.com/go/news .
Press release URL:
http://www.agilent.com/about/newsroom/presrel/2007/24sep-ca07056.html
Additional metadata keywords (for Web use only): Accelrys, resale agreement,
informatics
EDITORIAL CONTACTS:
Claudia Hachtel, Agilent Technologies
+49-7243-602 100
claudia_hachtel@agilent.com
Nicki Muir, Alto Marketing
+44-1489-55 76 72
nickim@alto-marketing.com
Sarah Perceval, Alto Marketing
+44-1489-55 76 72
sarahp@alto-marketing.com | |
|
